title: Commentary: is CRP ready for use to indicate response or remission with infliximab in Crohn's?
authors.affiliation: Department of Epidemiology and Public Health, University of Nottingham, UK. tim.card@nottingham.ac.uk
authors.forename: T
authors.initials: T
authors.lastname: Card
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000378:metabolism*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D015415:Biomarkers; D005765:Gastrointestinal Agents; D002097:C-Reactive Protein